Efficacy and safety of different doses of a slow-release corticosteroid implant for macular edema [Corrigendum]

Abstract

Liu QY, He MM, Shi H, et al. Drug Des Devel Ther. 2015;9: 2527–2535. In “Efficacy and safety of different doses of a slow release corticosteroid implant for macular edema: meta-analysis of randomized controlled trials” published May 2015, on page 2530, in Table 1 we have mistakenly stated the fluocinolone acetonide (FA) intravitreal inserts as Retisert® in the Campochiaro et al study; they were in fact the fluocinolone acetonide intravitreal inserts. We feel sorry about that, and we will be more rigorous to avoid any unnecessary confusion in the future. Read the original article